|
|
OTC Healthcare in Spain to 2013
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 193 seiten | |||||||||
| Inhalt der Studie: |
Introduction
This databook provides key data and information on the OTC healthcare market in Spain. This report is a comprehensive resource for market, category and segment level data including value.....
Introduction This databook provides key data and information on the OTC healthcare market in Spain. This report is a comprehensive resource for market, category and segment level data including value, distribution share and company & brand share. Scope *Contains information on:analgesics,medicated skin product,topical OTC,traditional,indigestion,cough&cold,plasters&Bandages,vitamins and first aid kits *Market,category and segment level information on value with historic (2003-2008) and forecast (2009-2013) data *Category level company and brand share as well as distribution share information for 2007 and 2008 *Review of the top two companies within the OTC healthcare market, including company overview, key facts and business description Highlights The market for OTC healthcare in Spain increased at a compound annual growth rate of 3.3% between 2003 and 2008. The cough and cold preparations category led the OTC healthcare market in Spain, accounting for a share of 22.4%. Leading players in Spanish OTC healthcare market include Johnson & Johnson, GlaxoSmithKline Plc and Sanofi-Aventis. Reasons to Purchase *Develop business strategies by understanding the quantitative trends within the OTC healthcare market in Spain *Design effective marketing and sales strategies by identifying key market categories and segments *Identify key players within the market to plan lucrative M&A, partnerships and agreements Report Highlights [Studien Infos ausblenden] |
|||||||||||
|
TABLE OF CONTENTS Chapter 1 Executive Summary 2 Summary market level: OTC healthcare 2 Summary category level: analgesics 3 Summary category level: topical OTC medicines 4 Summary category level: cough and cold preparations 5 Summary category level: indigestion preparations 6 Summary category level: medicated skin products 7 Summary category level: first aid kits 8 Summary category level: other OTC healthcare products 9 Summary category level: plasters & bandages 10 Summary category level: traditional medicines 11 Summary category level: vitamins and minerals 12 Chapter 2 Introduction 13 What is this report about? 13 How to use this report 13 Market definition 14 Chapter 3 Market Overview 30 Value analysis (Euro), 2003?08 30 Value analysis (Euro), 2008?13 32 Value analysis (US dollars), 2003?08 34 Value analysis (US dollars), 2008?13 35 Company and brand share analysis 37 Distribution analysis 44 Chapter 4 Leading Company Profiles 46 Johnson & Johnson 46 GlaxoSmithKline Plc 48 Chapter 5 Category Analysis: Analgesics 51 Value analysis (Euro), 2003?08 51 Value analysis (Euro), 2008?13 52 Value analysis (US dollars), 2003?08 54 Value analysis (US dollars), 2008?13 54 Company and brand share analysis 56 Distribution analysis 59 Chapter 6 Category Analysis: Topical OTC Medicines 61 Value analysis (Euro), 2003?08 61 Value analysis (Euro), 2008?13 62 Value analysis (US dollars), 2003?08 64 Value analysis (US dollars), 2008?13 65 Company and brand share analysis 67 Distribution analysis 69 Chapter 7 Category Analysis: Cough and Cold Preparations 71 Value analysis (Euro), 2003?08 71 Value analysis (Euro), 2008?13 72 Value analysis (US dollars), 2003?08 74 Value analysis (US dollars), 2008?13 75 Company and brand share analysis 77 Distribution analysis 80 Chapter 8 Category Analysis: Indigestion Preparations 82 Value analysis (Euro), 2003?08 82 Value analysis (Euro), 2008?13 83 Value analysis (US dollars), 2003?08 85 Value analysis (US dollars), 2008?13 85 Company and brand share analysis 87 Distribution analysis 90 Chapter 9 Category Analysis: Medicated Skin Products 92 Value analysis (Euro), 2003?08 92 Value analysis (Euro), 2008?13 93 Value analysis (US dollars), 2003?08 95 Value analysis (US dollars), 2008?13 96 Company and brand share analysis 98 Distribution analysis 101 Chapter 10 Category Analysis: First Aid Kits 103 Value analysis (Euro), 2003?08 103 Value analysis (Euro), 2008?13 104 Value analysis (US dollars), 2003?08 105 Value analysis (US dollars), 2008?13 105 Company and brand share analysis 106 Distribution analysis 109 Chapter 11 Category Analysis: Other OTC Healthcare Products 111 Value analysis (Euro), 2003?08 111 Value analysis (Euro), 2008?13 112 Value analysis (US dollars), 2003?08 114 Value analysis (US dollars), 2008?13 115 Company and brand share analysis 117 Distribution analysis 120 Chapter 12 Category Analysis: Plasters & Bandages 122 Value analysis (Euro), 2003?08 122 Value analysis (Euro), 2008?13 123 Value analysis (US dollars), 2003?08 125 Value analysis (US dollars), 2008?13 126 Company and brand share analysis 128 Distribution analysis 131 Chapter 13 Category Analysis: Traditional Medicines 133 Value analysis (Euro), 2003?08 133 Value analysis (Euro), 2008?13 134 Value analysis (US dollars), 2003?08 135 Value analysis (US dollars), 2008?13 135 Company and brand share analysis 136 Distribution analysis 139 Chapter 14 Category Analysis: Vitamins and Minerals 141 Value analysis (Euro), 2003?08 141 Value analysis (Euro), 2008?13 142 Value analysis (US dollars), 2003?08 144 Value analysis (US dollars), 2008?13 144 Company and brand share analysis 146 Distribution analysis 149 Chapter 15 Country Comparison 151 Value 151 Market share 155 Chapter 16 PESTLE Analysis 156 Summary 156 Political analysis 157 Economic analysis 160 Social analysis 165 Technological analysis 169 Legal analysis 173 Environmental analysis 176 Chapter 17 New Product Development 180 Product launches over time 180 Recent product launches 182 Chapter 18 Macroeconomic Profile 183 Macroeconomic indicators 183 Chapter 19 Research Methodology 188 Methodology overview 188 Secondary research 189 Market modeling 190 Creating an initial data model 190 Revising the initial data model 190 Creating a final estimate 191 Creating demographic value splits 191 Primary research 191 Data finalization 192 Ongoing research 192 Chapter 20 APPENDIX 193 Future readings 193 How to contact experts in your industry 193 Disclaimer 193 LIST OF FIGURES Figure 1: Spain OTC healthcare value and value forecast, 2003?13 (€m, nominal prices) 33 Figure 2: Spain OTC healthcare category growth comparison, by value, 2003?13 36 Figure 3: Spain OTC healthcare company share, by value, 2007?08 (%) 41 Figure 4: Spain OTC healthcare distribution channels, by value, 2007?08 (%) 45 Figure 5: Spain analgesics value and value forecast, 2003?13 (€m, nominal prices) 53 Figure 6: Spain analgesics category growth comparison, by value, 2003?13 55 Figure 7: Spain analgesics company share, by value, 2007?08 (%) 57 Figure 8: Spain analgesics distribution channels, by value, 2007?08 (%) 60 Figure 9: Spain topical OTC medicines value and value forecast, 2003?13 (€m, nominal prices) 63 Figure 10: Spain topical OTC medicines category growth comparison, by value, 2003?13 66 Figure 11: Spain topical OTC medicines distribution channels, by value, 2007?08 (%) 70 Figure 12: Spain cough and cold preparations value and value forecast, 2003?13 (€m, nominal prices) 73 Figure 13: Spain cough and cold preparations category growth comparison, by value, 2003?13 76 Figure 14: Spain cough and cold preparations company share, by value, 2007?08 (%) 78 Figure 15: Spain cough and cold preparations distribution channels, by value, 2007?08 (%) 81 Figure 16: Spain indigestion preparations value and value forecast, 2003?13 (€m, nominal prices) 84 Figure 17: Spain indigestion preparations category growth comparison, by value, 2003?13 86 Figure 18: Spain indigestion preparations company share, by value, 2007?08 (%) 88 Figure 19: Spain indigestion preparations distribution channels, by value, 2007?08 (%) 91 Figure 20: Spain medicated skin products value and value forecast, 2003?13 (€m, nominal prices) 94 Figure 21: Spain medicated skin products category growth comparison, by value, 2003?13 97 Figure 22: Spain medicated skin products company share, by value, 2007?08 (%) 99 Figure 23: Spain medicated skin products distribution channels, by value, 2007?08 (%) 102 Figure 24: Spain first aid kits value and value forecast, 2003?13 (€m, nominal prices) 104 Figure 25: Spain first aid kits company share, by value, 2007?08 (%) 107 Figure 26: Spain first aid kits distribution channels, by value, 2007?08 (%) 110 Figure 27: Spain other OTC healthcare products value and value forecast, 2003?13 (€m, nominal prices) 113 Figure 28: Spain other OTC healthcare products category growth comparison, by value, 2003?13 116 Figure 29: Spain other OTC healthcare products company share, by value, 2007?08 (%) 118 Figure 30: Spain other OTC healthcare products distribution channels, by value, 2007?08 (%) 121 Figure 31: Spain plasters & bandages value and value forecast, 2003?13 (€m, nominal prices) 124 Figure 32: Spain plasters & bandages category growth comparison, by value, 2003?13 127 Figure 33: Spain plasters & bandages company share, by value, 2007?08 (%) 129 Figure 34: Spain plasters & bandages distribution channels, by value, 2007?08 (%) 132 Figure 35: Spain traditional medicines value and value forecast, 2003?13 (€m, nominal prices) 134 Figure 36: Spain traditional medicines company share, by value, 2007?08 (%) 137 Figure 37: Spain traditional medicines distribution channels, by value, 2007?08 (%) 140 Figure 38: Spain vitamins and minerals value and value forecast, 2003?13 (€m, nominal prices) 143 Figure 39: Spain vitamins and minerals category growth comparison, by value, 2003?13 145 Figure 40: Spain vitamins and minerals company share, by value, 2007?08 (%) 147 Figure 41: Spain vitamins and minerals distribution channels, by value, 2007?08 (%) 150 Figure 42: Global OTC healthcare market split (value terms, 2008), top five countries 152 Figure 43: Global OTC healthcare market value, 2003–08, top five countries 154 Figure 44: Annual data review process 189 LIST OF TABLES Table 1: OTC healthcare category definitions 15 Table 2: OTC healthcare distribution channels 17 Table 3: Spain OTC healthcare value, 2003?08 (€m, nominal prices) 31 Table 4: Spain OTC healthcare value forecast, 2008?13 (€m, nominal prices) 32 Table 5: Spain OTC healthcare value, 2003?08 ($m, nominal prices) 34 Table 6: Spain OTC healthcare value forecast, 2008?13 ($m, nominal prices) 35 Table 7: Spain OTC healthcare brand share, by value, 2007?08 (%) 37 Table 8: Spain OTC healthcare value, by brand 2007?08 (€m, nominal prices) 39 Table 9: Spain OTC healthcare company share by value, 2007?08 (%) 42 Table 10: Spain OTC healthcare value, by company, 2007?08 (€m, nominal prices) 43 Table 11: Spain OTC healthcare distribution channels, by value, 2007?08 (%) 44 Table 12: Spain OTC healthcare value, by distribution channel, 2007?08 (€m, nominal prices) 44 Table 13: Johnson & Johnson key facts 46 Table 14: GlaxoSmithKline Plc key facts 48 Table 15: Spain analgesics value, 2003?08 (€m, nominal prices) 51 Table 16: Spain analgesics value forecast, 2008?13 (€m, nominal prices) 52 Table 17: Spain analgesics value, 2003?08 ($m, nominal prices) 54 Table 18: Spain analgesics value forecast, 2008?13 ($m, nominal prices) 54 Table 19: Spain analgesics brand share, by value, 2007?08 (%) 56 Table 20: Spain analgesics value, by brand 2007?08 (€m, nominal prices) 56 Table 21: Spain analgesics company share by value, 2007?08 (%) 58 Table 22: Spain analgesics value, by company, 2007?08 (€m, nominal prices) 58 Table 23: Spain analgesics distribution channels, by value, 2007?08 (%) 59 Table 24: Spain analgesics value, by distribution channel, 2007?08 (€m, nominal prices) 59 Table 25: Spain topical OTC medicines value, 2003?08 (€m, nominal prices) 61 Table 26: Spain topical OTC medicines value forecast, 2008?13 (€m, nominal prices) 62 Table 27: Spain topical OTC medicines value, 2003?08 ($m, nominal prices) 64 Table 28: Spain topical OTC medicines value forecast, 2008?13 ($m, nominal prices) 65 Table 29: Spain topical OTC medicines brand share, by value, 2007?08 (%) 67 Table 30: Spain topical OTC medicines value, by brand 2007?08 (€m, nominal prices) 67 Table 31: Spain topical OTC medicines company share by value, 2007?08 (%) 68 Table 32: Spain topical OTC medicines value, by company, 2007?08 (€m, nominal prices) 68 Table 33: Spain topical OTC medicines distribution channels, by value, 2007?08 (%) 69 Table 34: Spain topical OTC medicines value, by distribution channel, 2007?08 (€m, nominal prices) 69 Table 35: Spain cough and cold preparations value, 2003?08 (€m, nominal prices) 71 Table 36: Spain cough and cold preparations value forecast, 2008?13 (€m, nominal prices) 72 Table 37: Spain cough and cold preparations value, 2003?08 ($m, nominal prices) 74 Table 38: Spain cough and cold preparations value forecast, 2008?13 ($m, nominal prices) 75 Table 39: Spain cough and cold preparations brand share, by value, 2007?08 (%) 77 Table 40: Spain cough and cold preparations value, by brand 2007?08 (€m, nominal prices) 77 Table 41: Spain cough and cold preparations company share by value, 2007?08 (%) 79 Table 42: Spain cough and cold preparations value, by company, 2007?08 (€m, nominal prices) 79 Table 43: Spain cough and cold preparations distribution channels, by value, 2007?08 (%) 80 Table 44: Spain cough and cold preparations value, by distribution channel, 2007?08 (€m, nominal prices) 80 Table 45: Spain indigestion preparations value, 2003?08 (€m, nominal prices) 82 Table 46: Spain indigestion preparations value forecast, 2008?13 (€m, nominal prices) 83 Table 47: Spain indigestion preparations value, 2003?08 ($m, nominal prices) 85 Table 48: Spain indigestion preparations value forecast, 2008?13 ($m, nominal prices) 85 Table 49: Spain indigestion preparations brand share, by value, 2007?08 (%) 87 Table 50: Spain indigestion preparations value, by brand 2007?08 (€m, nominal prices) 87 Table 51: Spain indigestion preparations company share by value, 2007?08 (%) 89 Table 52: Spain indigestion preparations value, by company, 2007?08 (€m, nominal prices) 89 Table 53: Spain indigestion preparations distribution channels, by value, 2007?08 (%) 90 Table 54: Spain indigestion preparations value, by distribution channel, 2007?08 (€m, nominal prices) 90 Table 55: Spain medicated skin products value, 2003?08 (€m, nominal prices) 92 Table 56: Spain medicated skin products value forecast, 2008?13 (€m, nominal prices) 93 Table 57: Spain medicated skin products value, 2003?08 ($m, nominal prices) 95 Table 58: Spain medicated skin products value forecast, 2008?13 ($m, nominal prices) 96 Table 59: Spain medicated skin products brand share, by value, 2007?08 (%) 98 Table 60: Spain medicated skin products value, by brand 2007?08 (€m, nominal prices) 98 Table 61: Spain medicated skin products company share by value, 2007?08 (%) 100 Table 62: Spain medicated skin products value, by company, 2007?08 (€m, nominal prices) 100 Table 63: Spain medicated skin products distribution channels, by value, 2007?08 (%) 101 Table 64: Spain medicated skin products value, by distribution channel, 2007?08 (€m, nominal prices) 101 Table 65: Spain first aid kits value, 2003?08 (€m, nominal prices) 103 Table 66: Spain first aid kits value forecast, 2008?13 (€m, nominal prices) 104 Table 67: Spain first aid kits value, 2003?08 ($m, nominal prices) 105 Table 68: Spain first aid kits value forecast, 2008?13 ($m, nominal prices) 105 Table 69: Spain first aid kits brand share, by value, 2007?08 (%) 106 Table 70: Spain first aid kits value, by brand 2007?08 (€m, nominal prices) 106 Table 71: Spain first aid kits company share by value, 2007?08 (%) 108 Table 72: Spain first aid kits value, by company, 2007?08 (€m, nominal prices) 108 Table 73: Spain first aid kits distribution channels, by value, 2007?08 (%) 109 Table 74: Spain first aid kits value, by distribution channel, 2007?08 (€m, nominal prices) 109 Table 75: Spain other OTC healthcare products value, 2003?08 (€m, nominal prices) 111 Table 76: Spain other OTC healthcare products value forecast, 2008?13 (€m, nominal prices) 112 Table 77: Spain other OTC healthcare products value, 2003?08 ($m, nominal prices) 114 Table 78: Spain other OTC healthcare products value forecast, 2008?13 ($m, nominal prices) 115 Table 79: Spain other OTC healthcare products brand share, by value, 2007?08 (%) 117 Table 80: Spain other OTC healthcare products value, by brand 2007?08 (€m, nominal prices) 117 Table 81: Spain other OTC healthcare products company share by value, 2007?08 (%) 119 Table 82: Spain other OTC healthcare products value, by company, 2007?08 (€m, nominal prices) 119 Table 83: Spain other OTC healthcare products distribution channels, by value, 2007?08 (%) 120 Table 84: Spain other OTC healthcare products value, by distribution channel, 2007?08 (€m, nominal prices) 120 Table 85: Spain plasters & bandages value, 2003?08 (€m, nominal prices) 122 Table 86: Spain plasters & bandages value forecast, 2008?13 (€m, nominal prices) 123 Table 87: Spain plasters & bandages value, 2003?08 ($m, nominal prices) 125 Table 88: Spain plasters & bandages value forecast, 2008?13 ($m, nominal prices) 126 Table 89: Spain plasters & bandages brand share, by value, 2007?08 (%) 128 Table 90: Spain plasters & bandages value, by brand 2007?08 (€m, nominal prices) 128 Table 91: Spain plasters & bandages company share by value, 2007?08 (%) 130 Table 92: Spain plasters & bandages value, by company, 2007?08 (€m, nominal prices) 130 Table 93: Spain plasters & bandages distribution channels, by value, 2007?08 (%) 131 Table 94: Spain plasters & bandages value, by distribution channel, 2007?08 (€m, nominal prices) 131 Table 95: Spain traditional medicines value, 2003?08 (€m, nominal prices) 133 Table 96: Spain traditional medicines value forecast, 2008?13 (€m, nominal prices) 134 Table 97: Spain traditional medicines value, 2003?08 ($m, nominal prices) 135 Table 98: Spain traditional medicines value forecast, 2008?13 ($m, nominal prices) 135 Table 99: Spain traditional medicines brand share, by value, 2007?08 (%) 136 Table 100: Spain traditional medicines value, by brand 2007?08 (€m, nominal prices) 136 Table 101: Spain traditional medicines company share by value, 2007?08 (%) 138 Table 102: Spain traditional medicines value, by company, 2007?08 (€m, nominal prices) 138 Table 103: Spain traditional medicines distribution channels, by value, 2007?08 (%) 139 Table 104: Spain traditional medicines value, by distribution channel, 2007?08 (€m, nominal prices) 139 Table 105: Spain vitamins and minerals value, 2003?08 (€m, nominal prices) 141 Table 106: Spain vitamins and minerals value forecast, 2008?13 (€m, nominal prices) 142 Table 107: Spain vitamins and minerals value, 2003?08 ($m, nominal prices) 144 Table 108: Spain vitamins and minerals value forecast, 2008?13 ($m, nominal prices) 144 Table 109: Spain vitamins and minerals brand share, by value, 2007?08 (%) 146 Table 110: Spain vitamins and minerals value, by brand 2007?08 (€m, nominal prices) 146 Table 111: Spain vitamins and minerals company share by value, 2007?08 (%) 148 Table 112: Spain vitamins and minerals value, by company, 2007?08 (€m, nominal prices) 148 Table 113: Spain vitamins and minerals distribution channels, by value, 2007?08 (%) 149 Table 114: Spain vitamins and minerals value, by distribution channel, 2007?08 (€m, nominal prices) 149 Table 115: Global OTC healthcare market value, 2008 151 Table 116: Global OTC healthcare market split (value terms ($m), 2008), top five countries 154 Table 117: Leading players, top five countries 155 Table 118: Analysis of Spain’s political landscape 157 Table 119: Analysis of Spain’s economy 160 Table 120: Analysis of Spain’s social system 165 Table 121: Analysis of Spain’s technology landscape 169 Table 122: Comparative performance – patents 172 Table 123: Analysis of Spain’s legal landscape 173 Table 124: Analysis of Spain’s environmental landscape 176 Table 125: Spain OTC healthcare new product launches reports, by company (top five companies), 2008 180 Table 126: Spain OTC healthcare new product launches SKUs, by company (top five companies), 2008 180 Table 127: Spain OTC healthcare new product launches (reports), by flavor and fragrances 2008 181 Table 128: Spain OTC healthcare new product launches (reports), by ingredients (top 10 ingredients), 2008 181 Table 129: Spain OTC healthcare new product launches (reports), by package tags or claims (top 10 claims), 2008 182 Table 130: Spain OTC healthcare new product launches - recent five launches 2008 182 Table 131: Spain population, by age group, 2003?08 (millions) 183 Table 132: Spain population forecast, by age group, 2008?13 (millions) 184 Table 133: Spain population, by gender, 2003?08 (millions) 184 Table 134: Spain population forecast, by gender, 2008?13 (millions) 185 Table 135: Spain nominal GDP, 2003?08 (€bn, nominal prices) 185 Table 136: Spain nominal GDP forecast, 2008?13 (€bn, nominal prices) 185 Table 137: Spain real GDP, 2003?08 (€bn, 2000 prices) 186 Table 138: Spain real GDP forecast, 2008?13 (€bn, 2000 prices) 186 Table 139: Spain real GDP, 2003?08 ($bn, 2000 prices) 186 Table 140: Spain real GDP forecast, 2008?13 ($bn, 2000 prices) 187 Table 141: Spain consumer price index, 2003?08 (2000=100) 187 Table 142: Spain consumer price index, 2008?13 (2000=100) 187 [Inhaltsverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||


